Newborn bloodspot screening in the UK - Past, present and future

Annals of Clinical Biochemistry

Volumn 45, Issue 1, 2008, Pages 11-17

  Downing, Melanie ^a   Pollitt, Rodney ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE;

BLOOD ANALYSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; ENZYME DEFICIENCY; GALACTOSEMIA; GENETIC PRIVACY; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOCYSTINURIA; HUMAN; LABORATORY TEST; MAPLE SYRUP URINE DISEASE; METABOLIC DISORDER; NEWBORN SCREENING; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; TANDEM MASS SPECTROMETRY; THALASSEMIA; UNITED KINGDOM; ARTICLE; BLOOD; HISTORY; METHODOLOGY; NEWBORN; NEWBORN DISEASE;

ACER;

BLOOD CHEMICAL ANALYSIS; GREAT BRITAIN; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NEONATAL SCREENING;

EID: 41649106531     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2007.007127     Document Type: Review

References (33)

1. Bickel HJ, Gerrard J, Hickmans EM. The influence of phenylalanine intake on the chemistry and behaviour of a phenylketonuric child. Acta Paediatr 1954;43:64-88
2. Conference on phenylketonuria: treatment of phenylketonuria. Report to the Medical Research Council. BMJ 1963;i:1691-7
3. Smith I, Cook B, Beasley M. Review of neonatal screening programme for phenylketonuria. BMJ 1991;303:333-5
4. Streetly A, Grant C, Pollitt RJ, Addison GM. Survey of scope of neonatal screening in the United Kingdom. BMJ 1995;311:726
5. Pollitt RJ, Worthy E, Green A. Galactosaemia detection as a bonus from screening for phenylketonuria. J Inherit Metab Dis 1982;5:51-2
6. Department of Health and Social Security. Screening for Congenital Hypothyroidism. London: DHSS, 1980:HN(81)20
7. Dussault JH, Laberge C. Thyroxine (T4) determination in dried blood by radioimmunoassay: a screening method for congenital hypothyroidism. Union Med Can 1973;102:2062
8. Hulse JA, Grant DB, Clayton BE, et al. Population screening for congenital hypothyroidism. BMJ 1980;280:675-8
9. UK Newborn Screening Programme Centre. Newborn Blood Spot Screening in the UK. Policies and Standards. See updated version on http:// newbornscreening-bloodspot.org.uk (April 2005)
10. Bessman SP. Legislation and advances in medical knowledge - acceleration or inhibition? J Pediatr 1966;69:334-8
11. Guthrie R. Organisation of a regional newborn screening laboratory. In: Bickel H, Guthrie R, Hammersen G, eds. Neonatal Screening for Inborn Errors of Metabolism. Berlin: Springer-Verlag, 1980:259-70
12. Wilson JMG, Jungner G. Principles of Screening for Disease. Geneva: World Health Organization, 1968:26-39
13. Pollitt RJ, Green A, McCabe CJ, et al. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess 1997;1:1-203
14. Pollitt RJ. Principles and performance: assessing the evidence. Acta Paediatr Suppl 1999;88:110-14
15. Neonatal Screening in Europe. International Society for Newborn Screening Factsheet. See http://www.isns-neoscreening.org/pdf/(2003) Europeanscreening2003overview2.PDF (last accessed 30 January 2007)
16. Parsons EP, Clarke AJ, Hood K, Lycett E, Bradley DM. Newborn screening for Duchenne muscular dystrophy: a psychosocial study. Arch Dis Child Fetal Neonatal Ed 2002;86:F91-5
17. UK National Screening Committee. First Report of the National Screening Committee, 1998; Second Report of the UK National Screening Committee (undated). See http://www.nsc.nhs.uk (last accessed 8 February 2007)
18. Seymour CA, Thomason MJ, Chalmers RA, et al. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess 1997;1:1-95
19. NHS R&D Health Technology Assessment Programme. Health Technology Assessment. All reports are available on http://www.ncchta.org/
20. Working Party of the Clinical Genetics Society. Genetic Testing of Children. See http://www.clingensoc.org/Docs/Testing_of_Children1994.pdf (last accessed 31 January 2006)
21. Westminster Hall Debate. Hansard. 16 January 2001, Columns WH62-WH70. See http://www.parliament.the-stationery-office.co.uk/pa/cm/cmhansrd. htm
22. Cystic fibrosis newborn screening: evidence for benefit and current experience. Proceedings from a workshop, 20-21 November 2003, Atlanta, Georgia, USA. J Pediatr 2005;147(3 Suppl):S1-113
23. http://www.ich.ucl.ac.uk/newborn/download/ national_std_protocol_algorithm.pdf (last accessed 3 December 2006)
24. Shortland G, Besley G, Bohnam J, et al. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency (MCADD): findings from a multicentre prospective UK collaborative study (Abstract). J Inherit Metab Dis 2006;29(Suppl 1):19
25. Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P. Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007). J Inherit Metab Dis 2007;30:585-92
26. Pollitt RJ. International perspectives in newborn screening. J Inherit Metab Dis 2006;29:390-6
27. Gelb MH, Turecek F, Scott CR, Chamoles NA. Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 2006;29:397-404
28. Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Health Technol Assess 2004;8:1-121
29. Walter JH, Wraith JE, White FJ, Bridge C, Till J. Strategies for the treatment of cystathionine b-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr 1998;157(Suppl 2):S71-6
30. UK National Screening Committee. Amino acid Metabolism Disorder Screening. See http://www.library.nhs.uk/screening/ViewResource.aspx?resID= 88267&tabID=288&catID=10214 (last accessed 15 February 2007)
31. Lilford RJ, Thornton JG, Braunholtz D. Clinical trials and rare diseases: a way out of the conundrum. BMJ 1995;311:1621-5
32. Dezateux C. Evaluating newborn screening programmes based on dried blood spots: future challenges. Br Med Bull 1998;54:877-90
33. Streetley A, Corbett V. The National Newborn Screening Programme. An Audit of Phenylketonuria and Congenital Hypothyroidism Screening in England and Wales. London: Department of Public Health Medicine, UDMS Guy's and St Thomas's Medical Schools, 1998